近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
第一作者:
1.欧云生,权正学.水泥填塞瘤腔后误诊为肿瘤复发1例报告。中国罕少疾病杂志,1999,6(2):66-67.
2.欧云生,李怀先.胫骨应用解剖与胫骨型髓内分叉钉设计。实用骨科杂志,2001,7(2):101-104.
3.欧云生,李怀先.胫骨型髓内分叉钉治疗胫骨骨折的生物力学研究。骨与关节损伤杂志,2001,16(3):194-196.
4.欧云生,李怀先.胫骨髓内固定的治疗现状.重庆医科大学学报,2001;26(4):471-474.
5.欧云生,安洪,权正学,等.前路病灶彻底清除植骨内固定治疗胸腰椎结核.重庆医科大学学报,2003;28(5):617-619.
6.欧云生,安洪.鼠骨关节炎动物模型建立的现状.中国比较医学杂志(原中国实验动物学杂志),2004;14(1):41-44.
7.欧云生,安洪,权正学,等.原发性椎间盘炎的临床特点及前路手术探讨.颈腰痛杂志,2004;25(2):105-107.
8.欧云生,安洪,权正学,等.术后椎间盘炎的后路手术治疗.重庆医科大学学报,2004;29(2):197-199.
9.欧云生,安洪,权正学,等.两种术式治疗胸腰椎结核的疗效观察.实用骨科杂志,2004,10(4):323-325.
10.欧云生,安洪,权正学,等.一期病灶清除植骨内固定治疗颈椎结核并后凸畸形.重庆医科大学学报,2005;30(2):282-284.
11.欧云生,蒋电明,权正学,等.后路融合固定术治疗创伤性寰枢椎不稳与脱位.创伤外科杂志,2005;7(3):172-174.
12.欧云生,权正学,蒋电明,等.进一步提高骨科临床实习教学质量的思考.中国医学理论与实践,2005;15(7):1008,999.
13.欧云生,权正学,蒋电明,等.Ⅰ期病灶清除植骨内固定治疗腰椎间盘炎19例临床分析.重庆医学,2006;35(5):423-424.(论著)
14.欧云生,李怀先,安洪,等.胫骨型髓内分叉钉设计的应用解剖及生物力学测试.中国中医骨伤科杂志,2007;15(5):22-24.(基础研究)(统计源)
15.欧云生,蒋电明,权正学,等.n-HA/PA66复合生物活性人工椎体支撑植骨治疗胸腰椎爆裂型骨折合并截瘫.中国临床医学,2007;14(3):413-415.(论著)(统计源)
16.欧云生,安洪.高选择性非甾体抗炎药塞来昔布对大鼠骨关节炎关节软骨的影响.中国现代医学杂志,2007;17(18):2223-2225,2239.(论著)(CSCD扩展)
17.OUYunsheng,JIANGDianming,QUANZhengxue,etal.Theapplicationofartificialvertebralbodyofthebiomimeticn-HA/PA66compositesinanteriorsurgicaltreatmentofthoracolumbarfractures.ChineseJournalofReparativeandReconstructiveSurgery(中国修复重建外科杂志).2007;21(10):1084-1089.(论著)(CSCD核心)
18.欧云生,安洪.长期应用塞来昔布、布洛芬、吲哚美辛对大鼠骨关节炎关节软骨胶原代谢的影响.中国老年学杂志,2007;27(21):2070-2072.(基础研究)(CSCD核心)
19.欧云生,权正学,蒋电明,等.一期后路椎弓根内固定前路病灶清除植骨治疗腰骶段脊柱结核并后凸畸形.重庆医科大学学报,2008;33(1):119-121.(临床研究)(CSCD扩展)
20.欧云生,权正学,蒋电明,等.前路有限减压单节段植骨内固定治疗胸腰段DenisB型爆裂型骨折.中华创伤杂志,2008;24(3):208-211.(论著)(CSCD核心)
21.欧云生,李佳,蒋电明,等.新形势下医学生临床实习面临的冲击与对策.现代医药卫生,2009;25(19):3029-3030.
22.欧云生,蒋电明,权正学,等.n-HA/PA66复合生物活性融合器在颈椎病前路减压融合术中的初步临床应用研究.生物医学工程学杂志,2010;27(2):324-327.(论著)(CSCD核心)
23.欧云生,权正学,蒋电明,等.后路寰枢椎椎弓根钉固定技术治疗寰枢椎不稳或脱位的临床疗效及影像学评估.重庆医科大学学报,2010;35(10):1541-1544.(临床研究)(CSCD扩展库)
24.欧云生,刘显宏,权正学,等.人工椎间盘置换治疗外伤性颈椎间盘突出症初期临床疗效.脊柱外科杂志,2011;9(5):283-287.(临床研究)(统计源)
25.OuY,TanC,AnH(通讯作者),JiangD,QuanZ,TangK,LuoX.SelectiveCOX-2inhibitoramelioratesosteoarthritisbyrepressingapoptosisofchondrocyte.MedSciMonit.2012Jun1;18(6):BR247-252.(BasicResearch.SCI.IF(2012):1.358,ISSN:1234-1010)
26.OuYS,TanC,AnH(通讯作者),JiangDM,QuanZX,TangK,LuoXJ.TheeffectsofNSAIDsontypesI,II,andIIIcollagenmetabolisminaratosteoarthritismodel.RheumatolInt.2012Aug;32(8):2401-2405.(OriginalArticle.SCI.IF(2012):2.214,ISSN:0172-8172)
27.欧云生,李开庭,安洪,等.图式理论在医学研究生专业英语阅读能力培养中的应用.中华医学教育探索杂志;2012;11(8):816-818.(研究生教育)(统计源)
28.欧云生,杨洪宇,蒋电明,等.七年制医学生科研能力培养经验。医学研究生学报;2012;25(10):1081-1083.(论著)(统计源)
29.欧云生,安洪,谭超,等.3种非甾体抗炎药对大鼠骨关节炎关节软骨细胞IL-1β、TNF-α、IL-1α表达的影响.重庆医科大学学报;2013;38(3):260-264.(基础研究)(CSCD核心)
30.欧云生.下颈椎损伤分类系统和手术治疗策略。创伤外科杂志,2018;20(4):245-248.(专家论坛)(统计源)
通讯作者(研究生文章):
1.沈昌焕,欧云生(通讯作者).基质金属蛋白酶(MMPs)与椎间盘退变.颈腰痛杂志,2009,30(6):543-546.(文献综述)(统计源)
2.李佳,欧云生(通讯作者).椎间融合器的研究进展.中国临床医学.2009,16(6):550-553.(骨骼、综述)(统计源)
3.李佳,欧云生(通讯作者),权正学,等.后路经伤椎椎弓根螺钉结合短节段椎弓根螺钉系统内固定治疗胸腰椎爆裂型骨折.激光杂志,2010;31(5):69-71.(论著)(CSCD核心)
4.汪义,欧云生(通讯作者),蒋电明,等.椎弓根螺钉固定结合植入复合骨治疗胸腰椎骨折的研究.重庆医科大学学报,2010;35(11):1706-1709.(临床研究)(CSCD扩展)
5.谭超,欧云生(通讯作者),权正学,等.12例颈椎人工间盘置换治疗单、双节段颈椎病的初期临床疗效评价.重庆医科大学学报,2010;35(12):1894-1896.(临床研究)(CSCD扩展)
6.汪义,欧云生(通讯作者).基质金属蛋白酶在骨巨细胞瘤中的研究现状.激光杂志,2011;32(2):47-49.(综述)(CSCD核心)
7.李佳,欧云生(通讯作者),权正学,等.经伤椎椎弓根植骨联合伤椎椎弓根螺钉固定治疗胸腰段骨折.中国临床解剖学杂志,2011,29(3):356-360.(临床研究)(CSCD核心)
8.汪义,欧云生(通讯作者).基质金属蛋白酶在骨肿瘤中的表达与调控.重庆医学,2011;40(6):219-221.(综述)(CSCD扩展)
9.刘显宏,欧云生(通信作者),权正学,等.“漏斗技术”置入胸椎椎弓根螺钉在青少年特发性脊柱侧弯矫形术中的应用.重庆医科大学学报,2011,36(10):1264-1267.(临床研究)(CSCD扩展)
10.杨洪宇,欧云生(通信作者),权正学,等.比较经椎旁肌间隙入路与传统开放入路置入椎弓根螺钉治疗胸腰椎骨折的疗效.中国现代医学杂志,2011,21(27):3421-3424.(新进展研究)(CSCD扩展)
11.张乐,欧云生(通信作者),权正学,等.后路矫形侧连续置钉结合n-HA/PA66人工骨粒植骨治疗青少年特发性脊柱侧凸畸形.重庆医科大学学报,2011,36(12):1464-1467.(临床研究)(CSCD扩展)
12.陈鑫,欧云生(通讯作者),权正学,蒋电明,唐可,罗小辑.后路经椎弓根椎体楔形截骨矫形治疗胸腰椎陈旧性骨折伴后凸畸形。激光杂志,2012;33(1):85-87.(CSCD核心)
13.刘彪,欧云生(通讯作者),罗小辑,等.经后路腰椎融合术治疗老年性腰椎间盘突出症的临床疗效.中国老年学杂志,2012;32(10):2043-2045.(临床研究)(CSCD核心)
14.汪义,欧云生(通讯作者),权正学,蒋电明,安洪.基质金属蛋白酶7和基质金属蛋白酶抑制剂3在骨巨细胞瘤中的表达.中国肿瘤临床与康复,2012;19(2):109-112.(临床研究)(统计源)
15.李开庭,欧云生(通讯作者),权正学,罗小辑,唐可,蒋电明,安洪.“球尖”与“徒手”技术在胸椎椎弓根钉置入中的比较研究,重庆医科大学学报,2012,37(11):989-993.(临床研究)(CSCD扩展)
16.刘显宏,欧云生(通讯作者),蒋电明,等.n-HA/PA66与PEEKcage在颈前路椎间盘切除减压术后椎间隙重建的比较研究.中国临床解剖学杂志,2012,30(6):687-692.(临床研究)(CSCD核心)
17.张健,欧云生(通讯作者),蒋电明,安洪.影响医学本科生骨科实习效果的因素及对策.卫生职业教育,2012,30(24):84-85.
18.李胜华,欧云生(通讯作者).胸腰椎后凸畸形的后路截骨矫形术。创伤外科杂志2013;15(3):274-277(综述)(统计源)
19.王晓峰,欧云生(通信作者),唐可,等.经椎弓根截骨矫正强直性脊柱炎后凸畸形及疗效分析.中国现代医学杂志,2013,23(14):79-83。(新进展研究)(CSCD扩展)
20.刘渤,欧云生(通讯作者),蒋电明.以运动系统疾病为例浅谈器官系统教学模式的改革.中国高等医学教育,2013,7(199):68-69,106.(临床教学)
21.李开庭,白定群,欧云生(通信作者).光动力诱导肿瘤细胞死亡机制的研究进展.中华物理医学与康复杂志,2013,35(7):583-586.(综述)(CSCD核心)
22.涂平华,欧云生(通讯作者).PI3K/Akt信号转导通路与椎间盘退行性变的关系研究进展.医学综述,2013,19(20):3673-3675。(综述)(统计源)
23.张健,欧云生(通信作者),李开庭,等.后路椎间植骨融合联合椎弓根钉内固定选择性治疗合并椎间盘损伤的胸腰椎骨折脱位.重庆医科大学学报,2013,38(11):1255-1259.(论著)(CSCD核心)
24.杨博,欧云生(通信作者),张乐,等.持续闭合灌洗加多根引流系统治疗脊柱术后早期手术部位感染的疗效分析.中国现代医学杂志,2013,23(26):65-69。(新进展研究)(CSCD扩展)
25.王晓峰,欧云生(通讯作者),蒋电明,等.肾型n-HA/PA66腰椎间融合器在经椎间孔腰椎椎体间融合术中的有限元分析.中国临床解剖学杂志,2014,32(1):69-71.(临床生物力学)(CSCD核心)
26.LiKT,ZhangJ,DuanQQ,BiY,BaiDQ,OuYS(Correspondingauthors).Apoptosistriggeredbypyropheophorbide-αmethylester-mediatedphotodynamictherapyinagiantcelltumorinbone.LaserPhysics.24(2014),066002(7pp).Doi:10.1088/1054-660X/24/6/066002.(OriginalArticle.SCI.IF(2014):1.032,ISSN:1054-660X)
27.杨博,欧云生(通讯作者),蒋电明,安洪,刘渤,张健,李开庭.纳米羟基磷灰石/聚酰胺66椎间融合器用于腰椎退行性疾病手术治疗的初期临床疗效.生物医学工程学杂志,2014,31(5):1102-1106。Doi:10.7507/1001-5515.20140207(论著)(CSCD核心)
28.涂平华,李开庭,陈青,欧云生(通讯作者),白定群(通讯作者).芦荟大黄素介导的光动力诱导骨肉瘤MG63细胞自噬。第二军医大学学报,2014,35(12):1347-1352.Doi:10.3724/SP.J.1008.2014.01347(论著)(CSCD核心)
29.LiS,OuY(Correspondingauthor),LiuB,ZhuY,QuanZ,JiangD.Comparisonofosteotomyversusnon-osteotomyapproachforcongenitalscoliosis:aretrospectivestudyofthreesurgicaltechniques.ANZJSurg.2015Apr;85(4):249-54.doi:10.1111/ans.12886(OriginalArticle).IF(2015):1.158,ISSN:1445-1433)
30.张健,欧云生(通信作者),李开庭,蒋电明,杨博,龚梦嘉,何通川,毕杨.骨形态发生蛋白-7对胚胎小鼠髓核细胞成骨分化和Notch信号表达的影响。重庆医科大学学报,2015,40(2):164-170.DOI:10.13406/j.cnki.cyxb.000394(论著)(CSCD核心)
31.李胜华,欧云生(通信作者),刘渤,朱勇,权正学,蒋电明.单节段截骨治疗椎体形成不良型脊柱侧后凸畸形的疗效分析。重庆医科大学学报,2015,40(2):221-226.DOI:10.13406/j.cnki.cyxb.000288(论著)(CSCD核心)
32.杨东军,欧云生(通讯作者),涂平华,刘渤,朱勇,蒋电明。单侧椎弓根入路减压椎间融合治疗DenisB型胸腰椎爆裂型骨折。中国临床解剖学杂志,2015,33(2):218-222.(临床研究)(CSCD核心)DOI:10.13418/j.issn.1001-165x.2015.02.021
33.吴鹏,欧云生(通讯作者)。强直性脊柱炎的早期诊断及早期生物治疗的重要性.医学信息杂志.2015,28:348-349.(综述)(统计源)
34.杨博,欧云生(通讯作者),蒋电明,王晓峰,杨东军。肾型纳米羟基磷灰石/聚酰胺66腰椎融合器的体外生物力学研究。中国修复重建外科杂志,2015,29(6):746-750.(论著)(CSCD核心)。DOI:10.75071002-1892.20150160
35.胡钰铖,欧云生(通讯作者),刘渤,朱勇,赵增辉。前路复位融合内固定治疗IIa、II型Hangman骨折的疗效分析。颈腰痛杂志,2015,36(4):283-287.(临床研究)(统计源)。DOI:10.3969/j.issn.1005-7234.2015.04.005
36.黄秋,涂平华,欧云生(通讯作者),刘渤,陶勇,尹航。MPPa-PDT诱导人骨巨细胞瘤细胞自噬。第三军医大学学报,2015,37(17):1755-1760.(论著)(CSCD核心)。DOI:10.16016/j.1000-5404.201412133
37.吴鹏,欧云生(通讯作者),刘德龙,朱勇,赵增辉,蒋电明。后路经单侧椎弓根病灶清除植骨内固定治疗胸腰椎结核的疗效分析。中国修复重建外科杂志,2015,29(10):1259-1264.(论著)(CSCD核心)。DOI:10.7507/1002.1892.20150273
38.刘德龙,欧云生(通讯作者)。脊柱转移瘤的微创治疗现状。颈腰痛杂志,2015,36(9):414-417.(文献综述)(统计源)
39.邓乾兴,欧云生(通讯作者),刘渤,朱勇,蒋电明,黄秋,吴鹏。纤维羧甲基醚联合明胶海绵在腰椎后路手术中止血效果的临床观察。创伤外科杂志,2015,17(6):497-500.(论著)(统计源)。
40.邓乾兴,欧云生(通讯作者)。颈椎减压术后C5神经根麻痹研究现状。临床骨科杂志,2016,19(1):121-124.(综述)(统计源)。(DOI:10.3969/j.issn.1008-0287.2016.01.051)
41.TuPinghua,HuangQiu(共同第一作者),OuYunsheng(Correspondingauthor),DuXing,LiKaiting,TaoYong,YinHang.Aloe-Emodin-MediatedPhotodynamicTherapyInducesAutophagyandApoptosisinHumanOsteosarcomaCellLineMG-63throughROS-JNKsignalpathway.OncologyReports,35:3209-3215,2016.DOI:10.3892/or.2016.4703..ImpactFactor:2.662(2016).
42.DengQian-xing,OuYun-sheng(Correspondingauthor),ZhuYong,ZhaoZeng-hui,LiuBo,HuangQiu,DuXing,JiangDian-ming.Clinicaloutcomesoftwotypesofcagesusedintransforaminallumbarinterbodyfusionforthetreatmentofdegenerativelumbardiseases:n-HA/PA66cagesversusPEEKcages.JournalofMaterialsScience-MaterialsinMedicine.2016,27:102.(DOI:10.1007/s10856-016-5712-7).ImpactFactor:2.325(2016).
43.HuangQiu,OuYun-Sheng(Correspondingauthor),TaoYong,YinHang,TuPing-Hua.Apoptosisandautophagyinducedbypyropheophorbide-αmethylester-mediatedphotodynamictherapyinhumanosteosarcomaMG-63cells.Apoptosis.2016,21:749-760.DOI:10.1007/s10495-016-1243-4.ImpactFactor:3.833(2016).
44.邓乾兴,欧云生(通讯作者),蒋电明,刘渤,朱勇,赵增辉。n-HA/PA66椎间融合器在颈椎病前路椎间盘切除减压融合术的中期临床疗效。重庆医科大学学报,2016,41(5):489-494.(临床研究)(CSCD核心)。(DOI:10.13406/j.cnki.cyxb.000895)
45.陶勇,黄秋,欧云生(通信作者),尹航,陈艳阳,涂平华。焦脱镁叶绿酸-a甲酯介导的光动力疗法诱导人骨肉瘤MG-63细胞凋亡的研究。中国修复重建外科杂志,2016,30(6):669-674.(论著)(CSCD核心)。(DOI:10.7507/1002-1892.20160136)
46.LiKT,ChenQ,WangDW,DuanQQ,TianS,HeJW,OuYS(Correspondingauthor),BaiDQ(Correspondingauthor).MitochondrialpathwayandendoplasmicreticulumstressparticipateinthephotosensitizingeffectivenessofAE-PDTinMG63cells.CancerMedicine.2016Nov;5(11):3186-3193.doi:10.1002/cam4.895.ImpactFactor:3.362(2016).
47.杜兴,欧云生(通讯作者),朱勇,赵增辉,蒋电明。Dynesys动态稳定系统与腰后路椎间融合术治疗腰椎退行性变疗效的Meta分析。中国循证医学杂志,2016,16(12):1414-1422.(论著)(CSCD扩展)。(DOI:10.7507/1672-2531.20160214)
48.高永健,欧云生(通讯作者),邓乾兴,杜兴,李剑萧,朱勇,赵增辉,蒋电明。钛笼与髂骨块植骨修复椎骨缺损治疗胸腰椎结核的疗效比较。中国矫形外科杂志,2017,25(5):404-409.(临床论著)(CSCD核心)。(DOI:10.3977/j.issn.1005-8478.2017.05.05)
49.尹航,陶勇,欧云生(通信作者),黄秋,陈艳阳。MPPa-PDT抑制骨肉瘤MG63细胞侵袭和转移。中国肿瘤生物治疗杂志,2017,24(3):242-246.(基础研究)(CSCD核心)。(DOI:10.3872/j.issn.1007-385x.2017.03.005)
50.GaoYongjian,OuYunsheng(Correspondingauthor),DengQianxing,HeBin,DuXing,LiJianxiao.Comparisonbetweentitaniummeshandautogenousiliacbonegrafttorestorevertebralheightthroughposteriorapproachforthetreatmentofthoracicandlumbarspinaltuberculosis.PLoSONE.2017;12(4):e0175567.(ResearchArticle).http://doi.org/10.1371/journal.pone.0175567.ImpactFactor:2.766(2017).
51.赵增辉,朱勇,罗伟,杜兴,李剑箫,欧云生(通信作者),权正学。一期后路经单侧入路病灶清除植骨内固定治疗多节段胸腰椎结核。中国修复重建外科杂志,2017,31(9):1073-1079.(论著)(CSCD核心)。(DOI:10.7507/1002-1892.201703104)
52.陈艳阳,欧云生(通信作者),陶勇,尹航,黄秋,钟申熹,李剑箫。雷公藤红素通过内质网应激相关通路促进人骨肉瘤HOS细胞凋亡。肿瘤,2017,37(9):901-908.(基础研究)(CSCD核心)。(DOI:10.3781/j.issn.1000-7431.2017.11.276)
53.TaoYong,OuYunSheng(Correspondingauthor),YinHang,ChenYanyang,ZhongShenxi,GaoYongjian,ZhaoZenghui,HeBin,HuangQiu,DengQianxing.Establishmentandcharacterizationofhumanosteosarcomacellsresistanttopyropheophorbide-αmethylester-mediatedphotodynamictherapy.InternationalJournalOfOncology.2017,51:1427-1438.DOI:10.3892/ijo.2017.4136.ImpactFactor:3.333(2017).
54.杜兴,欧云生(通讯作者),朱勇,赵增辉,黄伟。咀嚼口香糖加速腰椎后路融合术后患者胃肠道功能恢复的临床观察。重庆医科大学学报,2018,43(10):1374-1378.(临床研究)(CSCD核心)。(DOI:10.13406/j.cnki.cyxb.001427)
55.李剑箫,欧云生(通信作者),高永健,邓乾兴,朱勇,赵增辉,陈艳阳。腰椎间隙鹑鸡肠球菌感染一例。中国修复重建外科杂志,2018,32(1):128.(短篇报道)(CSCD核心)。(DOI:10.7507/1002-1892.201706003)
56.高永健,欧云生(通信作者),权正学,蒋电明。胸腰椎脊柱结核外科治疗的研究进展。中国修复重建外科杂志,2018,32(1):112-117.(综述)(CSCD核心)。(DOI:10.7507/1002-1892.201705124)
57.邓乾兴,欧云生(通信作者),朱勇,赵增辉,黄秋。经椎间孔单节段腰椎椎间融合术后融合器下沉的危险因素分析。中华骨科杂志,2018,38(3):156-163.(临床论著)(CSCD核心)。DOI:10.3760/cma.j.issn.0253-2352.2018.03.005)
58.HeBin,ZhaoJinqiu,OuYunsheng(Correspondingauthor),JiangDianming.Biofunctionalizedpeptidenanofiber-basedcompositescaffoldsforboneregeneration.MaterSciEngCMaterBiolAppl.2018,90:728-738.(doi:10.1016/j.msec.2018.04.063).ImpactFactor:4.959(2018).
59.杜兴,欧云生(通信作者),朱勇,赵增辉,罗伟,何彬。颗粒植骨与横突植骨治疗单节段胸腰椎结核的短期疗效比较。解放军医学杂志,2018,43(5):434-439.(论著)(CSCD核心)。DOI:10.11855/j.issn.0577-7402.2018.05.14)
60.杜兴,欧云生(通信作者),李剑箫,胡鉴瑜,彭琪琪,李远强。超声骨刀在脊柱手术中应用的有效性与安全性的Meta分析。循证医学,2018,18(2):62-68.(论著)(CSCD扩展)。DOI:10.1209/j.issn.1671-5144.2018.02)
61.李剑箫,欧云生(通讯作者),高永建,赵增辉,朱勇,杜兴,陈艳阳。自体颗粒植骨与髂骨块植骨治疗单节段胸腰椎结核的疗效对比。中国临床解剖学杂志,2018,36(3):333-342.(临床研究)(CSCD核心)DOI:10.13418/j.issn.1001-165x.2018.03.020
62.彭琪琪,欧云生(通信作者),朱勇,赵增辉,罗伟,杜兴,李剑箫。后路病灶清除植骨内固定联合不同入路腰大肌脓肿清除局部化疗治疗胸腰椎结核。中国修复重建外科杂志,2018,32(7):912-919.(论著)(CSCD核心)。(DOI:10.7507/1002-1892.201801068)
63.ZhaoZenghui,GuoLiang,ZhuYong,LuoWei,OuYunsheng(Correspondingauthor),QuanZhengxue,JiangDianming.ClinicalUseofaNewNano-Hydroxyapatite/Polyamide66CompositeArtificialLaminainSpinalDecompressionSurgery:MoreThan4Years'Follow-Up.MedicalScienceMonitor.2018Aug11;24:5573-5579.(doi:10.12659/MSM.907958).(ClinicalResearch)ImpactFactor:1.98(2018).
64.ChenYanyang,OuYunsheng(Correspondingauthor),TaoYong,LiuHuzhe,YinHang,ZhongShenxi,YuHaoyang,ZhaoZenghui,HeBin.EffectandmechanismsofcelastrolontheapoptosisofHOSosteosarcomacells..OncologyReports.2018Oct;40(4):2260-2268.(doi:10.3892/or.2018.6619).ImpactFactor:3.041(2018).
65.ZhuYong,WuPeng,LuoWei,ZhaoZenghui,OuYunsheng(Correspondingauthor).Single-StagePosteriorInstrumentationandUnilateralTranspedicularDebridementfortheTreatmentofThoracolumbarTuberculosis:ThreeYearsofFollow-Up.WorldNeurosurg.2018Sep24.pii:S1878-8750(18)32131-4.doi:10.1016/j.wneu.2018.09.085.(OriginalArticle).ImpactFactor:1.723(2018).
66.徐帅,欧云生(通信作者),杜兴,朱勇,赵增辉,罗伟。SPECT/CT和MRI对脊柱肿瘤与脊柱结核的鉴别诊断价值。解放军医学杂志,2018,43(11):933-938.(论著)(CSCD核心)。(DOI:10.11855/j.issn.0577-7402.2018.11.05)
67.钟申熹,欧云生(通信作者),陈艳阳,余浩洋,左强。阻滞PERK信号通路增强人骨肉瘤HOS细胞对MPPa-PDT疗法的敏感性[J].第三军医大学学报,2019,41(2):100-109.(论著)(CSCD核心)。(DOI:10.16016/j.1000-5404.201808197)
68.彭琪琪,欧云生(通信作者),朱勇,赵增辉,罗伟,杜兴,李剑箫。手术时机对胸椎结核伴脊髓损害疗效的影响。中国修复重建外科杂志,2019,33(3):273-279.(论著)(CSCD核心)。(DOI:10.7507/1002-1892.201808071)
69.胡鉴瑜,欧云生(通信作者),朱勇,罗伟,赵增辉,杜兴,李剑箫。纳米羟基磷灰石/聚酰胺66椎间融合器用于腰椎退变性侧凸椎间融合的疗效。中国修复重建外科杂志,2019,33(3):287-295.(论著)(CSCD核心)。(DOI:10.7507/1002-1892.201807060)
70.DuXing,OuYun-sheng(Correspondingauthor),ZhuYong,ZhaoZeng-hui,LuoWei,HeBin,PengQi-qi,HuJian-yu.Onestageposteriordebridement,non-structuralbonegraftinthesurgicaltreatmentofsinglesegmentthoracictuberculosis:aretrospectivesingle-centercohortstudy.InternationalJournalofSurgery.2019,65:134-139.doi:10.1016/j.ijsu.2019.04.002.(OriginalResearch).ImpactFactor:3.158(2018).
71.WangBen,RanZhujie,LiuMengmengandOuYunsheng(Correspondingauthor).PrognosticsignificanceofpotentialimmunecheckpointmemberHHLA2inhumantumors:AComprehensiveAnalysis.FrontiersinImmunology.2019,10(July):1573.doi:10.3389/fimmu.2019.01573.(OriginalResearch).ImpactFactor:4.716(2018).
72.WangBen,LiJie,LiXin(共同第一作者)andOuYunsheng(Correspondingauthor).Identifyingprognosisandmetastasis_x001e_associatedgenesassociatedwithEwingsarcomabyweightedgeneco_x001e_expressionnetworkanalysis.OncologyLetters.2019,18:3527-3536.doi:10.3892/ol.2019.10681.(OriginalResearch).ImpactFactor:1.871(2018).
SCI文章(第一作者与通讯作者):
1.OuY,TanC,AnH(通讯作者),JiangD,QuanZ,TangK,LuoX.SelectiveCOX-2inhibitoramelioratesosteoarthritisbyrepressingapoptosisofchondrocyte.MedSciMonit.2012Jun1;18(6):BR247-252.(BasicResearch.SCI.IF(2012):1.358,ISSN:1234-1010)
2.OuYS,TanC,AnH(通讯作者),JiangDM,QuanZX,TangK,LuoXJ.TheeffectsofNSAIDsontypesI,II,andIIIcollagenmetabolisminaratosteoarthritismodel.RheumatolInt.2012Aug;32(8):2401-2405.(OriginalArticle.SCI.IF(2012):2.214,ISSN:0172-8172)
3.LiKT,ZhangJ,DuanQQ,BiY,BaiDQ,OuYS(Correspondingauthors).Apoptosistriggeredbypyropheophorbide-αmethylester-mediatedphotodynamictherapyinagiantcelltumorinbone.LaserPhysics.24(2014),066002(7pp).Doi:10.1088/1054-660X/24/6/066002.(OriginalArticle.SCI.IF(2014):1.032,ISSN:1054-660X)
4.LiS,OuY(Correspondingauthor),LiuB,ZhuY,QuanZ,JiangD.Comparisonofosteotomyversusnon-osteotomyapproachforcongenitalscoliosis:aretrospectivestudyofthreesurgicaltechniques.ANZJSurg.2015Apr;85(4):249-54.doi:10.1111/ans.12886(OriginalArticle.SCI.IF(2015):1.158,ISSN:1445-1433)
5.TuPinghua,HuangQiu(共同第一作者),OuYunsheng(Correspondingauthor),DuXing,LiKaiting,TaoYong,YinHang.Aloe-Emodin-MediatedPhotodynamicTherapyInducesAutophagyandApoptosisinHumanOsteosarcomaCellLineMG-63throughROS-JNKsignalpathway.OncologyReports,35:3209-3215,2016.DOI:10.3892/or.2016.4703.SCI(PrintISSN:1021-335X.OnlineISSN:1791-2431.ImpactFactor:2.662(2016).
6.DengQian-xing,OuYun-sheng(Correspondingauthor),ZhuYong,ZhaoZeng-hui,LiuBo,HuangQiu,DuXing,JiangDian-ming.Clinicaloutcomesoftwotypesofcagesusedintransforaminallumbarinterbodyfusionforthetreatmentofdegenerativelumbardiseases:n-HA/PA66cagesversusPEEKcages.JournalofMaterialsScience-MaterialsinMedicine.2016,27:102.(DOI:10.1007/s10856-016-5712-7).ImpactFactor:2.325(2016).
7.HuangQiu,OuYun-Sheng(Correspondingauthor),TaoYong,YinHang,TuPing-Hua.Apoptosisandautophagyinducedbypyropheophorbide-αmethylester-mediatedphotodynamictherapyinhumanosteosarcomaMG-63cells.Apoptosis.2016,21:749-760.DOI:10.1007/s10495-016-1243-4.ImpactFactor:3.833(2016).
8.LiKT,ChenQ,WangDW,DuanQQ,TianS,HeJW,OuYS(Correspondingauthor),BaiDQ(Correspondingauthor).MitochondrialpathwayandendoplasmicreticulumstressparticipateinthephotosensitizingeffectivenessofAE-PDTinMG63cells.CancerMedicine.2016Nov;5(11):3186-3193.doi:10.1002/cam4.895.ImpactFactor:3.362(2016).
9.GaoYongjian,OuYunsheng(Correspondingauthor),DengQianxing,HeBin,DuXing,LiJianxiao.Comparisonbetweentitaniummeshandautogenousiliacbonegrafttorestorevertebralheightthroughposteriorapproachforthetreatmentofthoracicandlumbarspinaltuberculosis.PLoSONE.2017;12(4):e0175567.(ResearchArticle).http://doi.org/10.1371/journal.pone.0175567.ImpactFactor:2.766(2017).
10.TaoYong,OuYunSheng(Correspondingauthor),YinHang,ChenYanyang,ZhongShenxi,GaoYongjian,ZhaoZenghui,HeBin,HuangQiu,DengQianxing.Establishmentandcharacterizationofhumanosteosarcomacellsresistanttopyropheophorbide-αmethylester-mediatedphotodynamictherapy.InternationalJournalOfOncology.2017,51:1427-1438.DOI:10.3892/ijo.2017.4136.ImpactFactor:3.333(2017).
11.HeBin,ZhaoJinqiu,OuYunsheng(Correspondingauthor),JiangDianming.Biofunctionalizedpeptidenanofiber-basedcompositescaffoldsforboneregeneration.MaterSciEngCMaterBiolAppl.2018,90:728-738.(doi:10.1016/j.msec.2018.04.063).ImpactFactor:4.959(2018).
12.ZhaoZenghui,GuoLiang,ZhuYong,LuoWei,OuYunsheng(Correspondingauthor),QuanZhengxue,JiangDianming.ClinicalUseofaNewNano-Hydroxyapatite/Polyamide66CompositeArtificialLaminainSpinalDecompressionSurgery:MoreThan4Years'Follow-Up.MedicalScienceMonitor.2018Aug11;24:5573-5579.(doi:10.12659/MSM.907958).(ClinicalResearch)ImpactFactor:1.98(2018).
13.ChenYanyang,OuYunsheng(Correspondingauthor),TaoYong,LiuHuzhe,YinHang,ZhongShenxi,YuHaoyang,ZhaoZenghui,HeBin.EffectandmechanismsofcelastrolontheapoptosisofHOSosteosarcomacells..OncologyReports.2018Oct;40(4):2260-2268.(doi:10.3892/or.2018.6619).ImpactFactor:3.041(2018).
14.ZhuYong,WuPeng,LuoWei,ZhaoZenghui,OuYunsheng(Correspondingauthor).Single-StagePosteriorInstrumentationandUnilateralTranspedicularDebridementfortheTreatmentofThoracolumbarTuberculosis:ThreeYearsofFollow-Up.WorldNeurosurg.2018Sep24.pii:S1878-8750(18)32131-4.doi:10.1016/j.wneu.2018.09.085.(OriginalArticle).ImpactFactor:1.723(2018).
15.DuXing,OuYun-sheng(Correspondingauthor),ZhuYong,ZhaoZeng-hui,LuoWei,HeBin,PengQi-qi,HuJian-yu.Onestageposteriordebridement,non-structuralbonegraftinthesurgicaltreatmentofsinglesegmentthoracictuberculosis:aretrospectivesingle-centercohortstudy.InternationalJournalofSurgery.2019,65:134-139.doi:10.1016/j.ijsu.2019.04.002.(OriginalResearch).ImpactFactor:3.158(2018).
16.WangBen,RanZhujie,LiuMengmengandOuYunsheng(Correspondingauthor).PrognosticsignificanceofpotentialimmunecheckpointmemberHHLA2inhumantumors:AComprehensiveAnalysis.FrontiersinImmunology.2019,10(July):1573.doi:10.3389/fimmu.2019.01573.(OriginalResearch).ImpactFactor:4.716(2018).
17.WangBen,LiJie,LiXin(共同第一作者)andOuYunsheng(Correspondingauthor).IdentifyingprognosisandmetastasisassociatedgenesassociatedwithEwingsarcomabyweightedgenecoexpressionnetworkanalysis.OncologyLetters.2019,18:3527-3536.doi:10.3892/ol.2019.10681.(OriginalResearch).ImpactFactor:1.871(2018).
著作教材
参编专著:
1.欧云生,安洪。外科症状鉴别诊断。上海科学技术出版社。2004年11月,第一版。486-497。
2.欧云生.老年人运动系统疾病。老年医学(M)(参编)。科学出版社,北京。2008(5):375-377,379-389.(约1.32万字、1.98分)